Myth: "Medical weight loss just means Ozempic"
GLP-1s come up often, but they're one tool among several a clinician might reach for. A program built around a full metabolic panel can point toward a GLP-1, a different medication, or a combination — the panel decides, not a brand name.
Myth: "Everyone gets the same dose"
Dosing gets titrated at follow-up visits based on how an individual is actually responding — tolerance, side effects, and results all vary person to person. A starting dose is a starting point, not a fixed prescription that stays the same for the whole program.
Myth: "You'll lose muscle right along with the fat"
That's a real risk if body composition isn't being tracked, not an inevitability. Watching fat loss against lean mass over time — not just the number on a scale — is what lets a protocol get adjusted specifically to protect muscle while the fat loss continues.
Myth: "Once you stop, you gain it all back immediately"
What happens after a program ends depends heavily on the habits and body composition built during it, not just the medication itself. This is a legitimate, worthwhile question to bring to a visit — the honest answer depends on the individual case, not a blanket rule either way.
What actually determines the outcome
Labs, history, and body composition tracked over time — not which medication gets mentioned first in a conversation.